Association of lipid rafts cholesterol with clinical profile in fragile X syndrome.

Autor: Toupin A; Department of Biochemistry and Functional Genomics, Université de Sherbrooke, Sherbrooke, QC, Canada., Benachenhou S; Department of Biochemistry and Functional Genomics, Université de Sherbrooke, Sherbrooke, QC, Canada., Abolghasemi A; Department of Biochemistry and Functional Genomics, Université de Sherbrooke, Sherbrooke, QC, Canada., Laroui A; Department of Biochemistry and Functional Genomics, Université de Sherbrooke, Sherbrooke, QC, Canada., Galarneau L; Department of Biochemistry and Functional Genomics, Université de Sherbrooke, Sherbrooke, QC, Canada., Fülöp T; Research Center on Aging, CIUSSS de l'Estrie-CHUS, Sherbrooke, QC, Canada.; Department of Medicine, Université de Sherbrooke, Sherbrooke, QC, Canada., Corbin F; Department of Biochemistry and Functional Genomics, Université de Sherbrooke, Sherbrooke, QC, Canada., Çaku A; Department of Biochemistry and Functional Genomics, Université de Sherbrooke, Sherbrooke, QC, Canada. Artuela.S.Caku@USherbrooke.ca.
Jazyk: angličtina
Zdroj: Scientific reports [Sci Rep] 2022 Feb 21; Vol. 12 (1), pp. 2936. Date of Electronic Publication: 2022 Feb 21.
DOI: 10.1038/s41598-022-07064-z
Abstrakt: Fragile X syndrome (FXS) is the most prevalent monogenic cause of intellectual disability and autism spectrum disorder (ASD). Affected individuals have a high prevalence of hypocholesterolemia, however, the underlying mechanisms and the clinical significance remains unknown. We hypothesized that decrease in the plasma cholesterol levels is associated with an alteration of cholesterol content within the lipid rafts (LRs) which ultimately affects the clinical profile of FXS individuals. The platelets LRs were isolated by ultracentrifugation on sucrose gradient from 27 FXS and 25 healthy controls, followed by measurements of proteins, cholesterol, and gangliosides content. Autistic and adaptive behaviour of affected individuals were respectively assessed by the Social Communication Questionnaire and Adaptive Behavior Assessment System. Our results suggest a decrease in the cholesterol content of LRs in FXS individuals as compared to controls. As opposed to controls, LR cholesterol was significantly associated with plasma total cholesterol (r = 0.47; p = 0.042) in the FXS group. Furthermore, the correlation between LRs cholesterol and the clinical profile showed a significant association with autistic traits (r = - 0.67; p < 0.001) and adaptative behavior (r = 0.70; p < 0.001). These results support the clinical significance of LR cholesterol alterations in FXS. Further studies are warranted to investigate the implication of LRs in FXS pathophysiology and ASD.
(© 2022. The Author(s).)
Databáze: MEDLINE
Nepřihlášeným uživatelům se plný text nezobrazuje